← Back to patent-cliff list
Melanotan II
Tier C — Watch / tradeMelanotan II
The University Of Arizona
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：MCRs
Brand：Erectide
Indications (approved)：Vitiligo, Erectile dysfunction, Physiological sexual dysfunction
Regional status
US
-
EU
-
China
Phase II
2026-02-02
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Also available in our peptide catalogue
Frequently asked questions
What are the approved indications of Melanotan II?
Approved indications include: Vitiligo, Erectile dysfunction, Physiological sexual dysfunction.
When does the Melanotan II patent expire?
No public expiry year is available for Melanotan II yet; this page updates once verified.
How do I get a quote for Melanotan II intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29